TY - JOUR
T1 - Mechanisms of nitric oxide-independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries
AU - Jiang, Fan
AU - Li, Chun Guang
AU - Rand, Michael J.
PY - 2000
Y1 - 2000
N2 - 1. In rat isolated renal artery segments contracted with 0.1 μM phenylephrine and in the presence of the NO synthase inhibitor N(ω)-nitro-L-arginine methyl ester (L-NAME), carbachol and acetylcholine produced endothelium-dependent relaxations. The mechanisms underlying these relaxations were studied. 2. These relaxations were not affected by ODQ (1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one) or indomethacin. In arteries contracted with 20-30 mM K+, L-NAME-resistant relaxations induced by carbachol and acetylcholine were virtually absent. 3. The Na+-K+ ATPase inhibitor ouabain reduced these relaxations in a concentration-dependent manner. 4. In K+-free media, addition of K+ (5 mM) produced 90.5 ± 3.9% (n = 3) relaxation of phenylephrine-induced tone. This relaxation was endothelium-independent and ouabain-sensitive. 5. Tetraethylammonium (TEA), charybdotoxin (ChTX) and iberiotoxin (IbTX) reduced the sensitivity of carbachol-induced relaxations, but did not change the maximal response. These relaxations were not altered by 4-aminopyridine (4-AP), glibenclamide or apamin. Acetylcholine (1 μM)-induced relaxation was reduced by ChTX, but not by TEA or IbTX. 6. The cytochrome P450 inhibitor miconazole, but not 17-octadecynoic acid, reduced the sensitivity of carbachol-induced relaxations, without changing the maximal response. 7. In conclusion, in rat isolated renal arteries, acetylcholine and carbachol produced a non-NO/non-PGI2 relaxation which is mediated by an endothelium-derived hyperpolarizing factor (EDHF). This factor does not appear to be a cytochrome P450 metabolite. The inhibition by ouabain of these relaxations suggests the possible involvement of Na+-K+ ATPase activation in EDHF responses, although other mechanisms cannot be totally ruled out.
AB - 1. In rat isolated renal artery segments contracted with 0.1 μM phenylephrine and in the presence of the NO synthase inhibitor N(ω)-nitro-L-arginine methyl ester (L-NAME), carbachol and acetylcholine produced endothelium-dependent relaxations. The mechanisms underlying these relaxations were studied. 2. These relaxations were not affected by ODQ (1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one) or indomethacin. In arteries contracted with 20-30 mM K+, L-NAME-resistant relaxations induced by carbachol and acetylcholine were virtually absent. 3. The Na+-K+ ATPase inhibitor ouabain reduced these relaxations in a concentration-dependent manner. 4. In K+-free media, addition of K+ (5 mM) produced 90.5 ± 3.9% (n = 3) relaxation of phenylephrine-induced tone. This relaxation was endothelium-independent and ouabain-sensitive. 5. Tetraethylammonium (TEA), charybdotoxin (ChTX) and iberiotoxin (IbTX) reduced the sensitivity of carbachol-induced relaxations, but did not change the maximal response. These relaxations were not altered by 4-aminopyridine (4-AP), glibenclamide or apamin. Acetylcholine (1 μM)-induced relaxation was reduced by ChTX, but not by TEA or IbTX. 6. The cytochrome P450 inhibitor miconazole, but not 17-octadecynoic acid, reduced the sensitivity of carbachol-induced relaxations, without changing the maximal response. 7. In conclusion, in rat isolated renal arteries, acetylcholine and carbachol produced a non-NO/non-PGI2 relaxation which is mediated by an endothelium-derived hyperpolarizing factor (EDHF). This factor does not appear to be a cytochrome P450 metabolite. The inhibition by ouabain of these relaxations suggests the possible involvement of Na+-K+ ATPase activation in EDHF responses, although other mechanisms cannot be totally ruled out.
KW - Acetylcholine
KW - Carbachol
KW - EDHF
KW - EDRF
KW - Ouabain
KW - Renal artery (rat)
UR - http://www.scopus.com/inward/record.url?scp=0033928916&partnerID=8YFLogxK
U2 - 10.1038/sj.bjp.0703408
DO - 10.1038/sj.bjp.0703408
M3 - Article
AN - SCOPUS:0033928916
SN - 0007-1188
VL - 130
SP - 1191
EP - 1200
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 6
ER -